This is a multicenter open-label extension (OLE) study to assess the long-term safety and efficacy of bempedoic acid (ETC-1002) 180 mg.
The purpose of this study is to characterize the safety and tolerability of long-term administration of bempedoic acid (ETC-1002) 180 mg and the efficacy of long-term administration of ETC-1002.
Please complete the form below if you are interested in joining a clinical study. Please note that not all who apply are accepted into a trial.
Sign up with your name and email address to obtain ongoing updates. Please know that you can ‘opt out’ at any time.